Search Results - "Magliocca, J. F."

A Comparison of Alemtuzumab with Basiliximab Induction in Simultaneous Pancreas–Kidney Transplantation by Magliocca, J. F., Odorico, J. S., Pirsch, J. D., Becker, Y. T., Knechtle, S. J., Leverson, G. E., Sollinger, H. W.

“…Alemtuzumab is a humanized, rat monoclonal antibody directed against the CD52 antigen. After binding, alemtuzumab causes profound and durable depletion and has…”
Get full text

Liver Transplantation From Uncontrolled DCD Donors: It's Time to Go Back to Basics by Magliocca, J. F.

“…One of the most experienced groups in the use of uncontrolled donation after circulatory death livers takes us back to the basics of liver transplantation…”
Get full text

Elevated Incidence of Posttransplant Erythrocytosis After Simultaneous Pancreas Kidney Transplantation by Guerra, G., Indahyung, R., Bucci, C. M., Schold, J. D., Magliocca, J. F., Meier‐Kriesche, H.‐U.

“…Posttransplant erythrocytosis (PTE) poses a potential risk of thrombosis in kidney transplantation. Clinical observation of our systemically drained…”
Get full text

Successful Treatment of Invasive Mucormycosis in a Liver Transplant Patient by Arm Amputation by Iida, T, Sawada, N, Takahashi, M, Zendejas, I.R, Kayler, L.K, Magliocca, J.F, Kim, R.D, Hemming, A.W, Fujita, S

“…Abstract Mucormycosis is an uncommon but frequently fatal infectious complication after solid organ transplantation. We describe successful treatment of…”
Get full text

PROviding Better ACcess To ORgans: A comprehensive overview of organ‐access initiatives from the ASTS PROACTOR Task Force by Hobeika, M. J., Miller, C. M., Pruett, T. L., Gifford, K. A., Locke, J. E., Cameron, A. M., Englesbe, M. J., Kuhr, C. S., Magliocca, J. F., McCune, K. R., Mekeel, K. L., Pelletier, S. J., Singer, A. L., Segev, D. L.

“…The American Society of Transplant Surgeons (ASTS) PROviding better Access To Organs (PROACTOR) Task Force was created to inform ongoing ASTS organ access…”
Get full text

Response: DonorNet and the Potential Effects on Organ Utilization by Kayler, L. K., Schold, J. D., Magliocca, J. F.

Get full text

Transmission of factor VII deficiency through liver transplantation by Guy, S R, Magliocca, J F, Fruchtman, S, McDonough, P, Emre, S, Kim-Schluger, L, Sheiner, P A, Fishbein, T M, Schwartz, M E, Miller, C M

“…The liver is the primary site of synthesis for the majority of coagulation factors. There are published accounts of liver donor-to-recipient transmission of…”
Get more information

Long-term medical complications in patients surviving > or = 5 years after liver transplant by Sheiner, P A, Magliocca, J F, Bodian, C A, Kim-Schluger, L, Altaca, G, Guarrera, J V, Emre, S, Fishbein, T M, Guy, S R, Schwartz, M E, Miller, C M

“…Short-term outcomes of liver transplantation are well reported. Little is known, however, about long-term results in liver recipients surviving > or =5 years…”
Get full text

The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation by Magliocca, Joseph F, Knechtle, Stuart J

“…Alemtuzumab is a monoclonal anti-CD52 antibody, which has been used extensively off label in solid organ transplantation. Its primary use has been as an…”
Get more information

Significantly Greater Hazard Associated with the Use of Older Donor Livers in HCV+ Recipients: 452 by Magliocca, J. F., Kayler, L. K., Hanish, S. I., Knechtle, S. J., Schold, J. D.

Get full text

Significantly Greater Hazard Associated with the Use of Older Donor Livers in HCV+ Recipients: 452 by Magliocca, J. F., Kayler, L. K., Hanish, S. I., Knechtle, S. J., Schold, J. D.

Get full text

OUTCOMES OF LIVER TRANSPLANTATION WITH DCD LIVERS ARE EQUIVALENT REGARDLESS OF RECIPIENT HCV STATUS: 2012 by Zendejas, I., Schold, J., Kayler, L. K., Magliocca, J. F.

Get full text

PORTAL VENOUS DRAINAGE OF PANCREAS ALLOGRAFTS OFFERS NO SURVIVAL BENEFIT TO PATIENTS UNDERGOING SPK AND MAY RESULT IN HIGHER EARLY REJECTION RATES: 2760 by Sokolich, J., Krishnamurthi, V., Garzon, P., Kayler, L. K., Schold, J. D., Magliocca, J. F.

Get full text

SIGNIFICANT INTERACTION BETWEEN DONOR AND RECIPIENT AGE IN PATIENTS UNDERGOING SIMULTANEOUS KIDNEY/PANCREAS TRANSPLANTATION: 3139 by Garzon, P., Krishnamurthi, V., Sokolich, J., Kayler, L. K., Schold, J. D., Magliocca, J. F.

Get full text

1H, 15N and 13C resonance assignments and secondary structure of apo liver fatty acid-binding protein by Wang, H, He, Y, Hsu, K T, Magliocca, J F, Storch, J, Stark, R E

Get full text

Solitary common iliac artery inflammatory aneurysm in a healthy woman: case report and review of the literature by Magliocca, Joseph F, Faerber, Gary J, Upchurch, Jr, Gilbert R

“…Inflammatory aneurysms represent only 3-10% of all aortoiliac aneurysms and tend to be more common in men. We report a case of a solitary inflammatory aneurysm…”
Get more information

Extracorporeal Support for Organ Donation after Cardiac Death Effectively Expands the Donor Pool by Magliocca, Joseph F., Magee, John C., Rowe, Stephen A., Gravel, Mark T., Chenault, Richard H., Merion, Robert M., Punch, Jeffrey D., Bartlett, Robert H., Hemmila, Mark R.

“…BACKGROUND:We sought to evaluate the effect on short-term outcomes of normothermic, extracorporeal perfusion (ECMO) for donation of abdominal organs for…”
Get full text

EXTRACORPOREAL SUPPORT FOR ORGAN DONATION AFTER CARDIAC DEATH by Magliocca, J F, Arenas, J D, Rowe, S M, Gravel, M T, Chenault, R H, Merion, R M, Punch, J D, Bartlett, R H, Hemmila, M R

Get full text